Lupin recalls 12k bottles of antidepressant

Lupin Pharmaceuticals voluntarily recalled 12,480 bottles of its Paroxetine extended-release antidepressant tablets, reports The Economic Times.

Here are three things to know.

  1. The 12.5 milligram dose of the medication is being pulled off the market over failed dissolution specifications.

  1. Paroxetine is used to treat patients with depression, panic disorder and social anxiety disorder. 

  1. The Food and Drug Administration labeled the recall as a Class III event, meaning the quality issue is not likely to cause adverse health risks to patients.

More articles on supply chain:

Herbal coffee recalled for containing erectile dysfunction drug ingredien
Puma Biotech earns FDA approval for breast cancer drug
A supply chain expert on what your performance dashboard is missing

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars